Tempest Therapeutics, Inc.TPSTNASDAQ
Loading
Year-over-year earnings per share growth rate
3Y CAGR
+55.5%/yr
vs +45.8%/yr prior
Acceleration
+9.7pp
Accelerating
Percentile
P87
Within normal range
vs 3Y Ago
3.8x
Strong expansion
Streak
2 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q3 2025 | 61.84% |
| Q2 2025 | 34.49% |
| Q1 2025 | -532.00% |
| Q4 2024 | -21.95% |
| Q3 2024 | 2.38% |
| Q2 2024 | -16.67% |
| Q1 2024 | -2.86% |
| Q4 2023 | 27.08% |
| Q3 2023 | 11.11% |
| Q2 2023 | 6.90% |
| Q1 2023 | 38.95% |
| Q4 2022 | -43.94% |
| Q3 2022 | 16.46% |
| Q2 2022 | 33.05% |
| Q1 2022 | -1.72% |
| Q4 2021 | 4.13% |
| Q3 2021 | 84.14% |
| Q2 2021 | -841.98% |
| Q1 2021 | 82.66% |
| Q4 2020 | -469.51% |
| Q3 2020 | -3.80% |
| Q2 2020 | 83.08% |
| Q1 2020 | 65.96% |
| Q4 2019 | -5.54% |
| Q3 2019 | -17.86% |
| Q2 2019 | 4.83% |
| Q1 2019 | -60.97% |
| Q4 2018 | 79.83% |
| Q3 2018 | 26.29% |
| Q2 2018 | -4.33% |
| Q1 2018 | 13.57% |
| Q4 2017 | 8.95% |
| Q3 2017 | 48.58% |
| Q2 2017 | -22.09% |
| Q1 2017 | 34.22% |
| Q4 2016 | -17.38% |
| Q3 2016 | 12.50% |
| Q2 2016 | 14.66% |
| Q1 2016 | 4.07% |
| Q4 2015 | -14.94% |